Most research intensive

Research and development as a share of revenue: how much of every dollar goes back into what comes next.

The top 50 US-listed companies above $2B, recomputed each night from SEC filings.

Technology takes 6 of the top ten places. Atlassian Corporation leads at 49.7%, and the middle of the list sits at 19.8% (Amgen).

The wider list: the R&D leaders screen.

  1. #1TechnologyTEAMAtlassian Corporation49.7%$3.3B in FY2026
  2. #2TechnologyDDOGDatadog45.2%$1.5B in FY2025
  3. #3TechnologySNOWSnowflake Inc.42.0%$2.0B in FY2026
  1. 4REGNRegeneron Pharmaceuticals$5.9B in FY202540.8%
  2. 5ONCBeOne Medicines AG$2.1B in FY202540.2%
  3. 6ALABAstera Labs, Inc.$304M in FY202535.7%
  4. 7SNPSSynopsys, Inc.$2.5B in FY202535.1%
  5. 8VRTXVertex Pharmaceuticals$3.9B in FY202532.6%
  6. 9CRWDCrowdStrike$1.4B in FY202628.8%
  7. 10METAMeta Platforms$57.4B in FY202528.5%
  8. 11WDAYWorkday, Inc.$2.7B in FY202628.1%
  9. 12NTRANatera, Inc.$624M in FY202527.1%
  10. 13INTCIntel$13.8B in FY202526.1%
  11. 14MRVLMarvell Technology, Inc.$2.1B in FY202625.3%
  12. 15MRKMerck & Co.$15.8B in FY202524.3%
  13. 16VEEVVeeva Systems$767M in FY202624.0%
  14. 17QCOMQualcomm$10.2B in FY202623.7%
  15. 18NETCloudflare, Inc.$512M in FY202523.6%
  16. 19AMDAdvanced Micro Devices$8.1B in FY202523.4%
  17. 20MCHPMicrochip Technology$1.1B in FY202623.0%
  18. 21ADSKAutodesk$1.6B in FY202622.8%
  19. 22NOWServiceNow$3.0B in FY202522.3%
  20. 23PANWPalo Alto Networks$2.6B in FY202622.2%
  21. 24BMYBristol Myers Squibb$10.0B in FY202520.6%
  22. 25LLYLilly (Eli)$13.3B in FY202520.5%
  23. 26AMGNAmgen$7.3B in FY202519.8%
  24. 27GILDGilead Sciences$5.8B in FY202519.7%
  25. 28MSTRStrategy Inc$94M in FY202519.7%
  26. 29NXPINXP Semiconductors$2.4B in FY202519.2%
  27. 30ABNBAirbnb$2.4B in FY202519.2%
  28. 31RPRXRoyalty Pharma plc$452M in FY202519.0%
  29. 32KEYSKeysight Technologies$1.0B in FY202518.7%
  30. 33EWEdwards Lifesciences$1.1B in FY202517.8%
  31. 34CIENCiena$848M in FY202517.8%
  32. 35AVGOBroadcom$11.0B in FY202517.2%
  33. 36PFEPfizer$10.4B in FY202516.7%
  34. 37ADIAnalog Devices$1.8B in FY202516.0%
  35. 38TERTeradyne$505M in FY202515.8%
  36. 39INTUIntuit$3.4B in FY202615.7%
  37. 40GRMNGarmin$1.1B in FY202515.5%
  38. 41ORCLOracle Corporation$10.3B in FY202615.3%
  39. 42GOOGLAlphabet Inc.$61.1B in FY202515.2%
  40. 43CSCOCisco$9.6B in FY202615.1%
  41. 44ABBVAbbVie$9.1B in FY202514.9%
  42. 45EBAYeBay Inc.$1.6B in FY202514.8%
  43. 46CRMSalesforce$6.0B in FY202614.4%
  44. 47ANETArista Networks$1.2B in FY202513.7%
  45. 48MPWRMonolithic Power Systems$382M in FY202513.7%
  46. 49ISRGIntuitive Surgical$1.3B in FY202513.0%
  47. 50AMATApplied Materials$3.6B in FY202512.6%

Other boards

Paid before they payHighest return on capital employedBiggest real buybacksMost revenue paid in stockMost cash over debtPiotroski F-Score of 9Longest wait for cashFastest-growing dividendsBiggest insider buyingFastest sales growthMost held by ETFs